ALRN - Aileron Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 520.93M
Enterprise Value 313.95M
Trailing P/E N/A
Forward P/E 1-0.90
PEG Ratio (5 yr expected) 1-0.44
Price/Sales (ttm)N/A
Price/Book (mrq)0.91
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.46

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-55.61%
Return on Equity (ttm)-115.83%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-18.45M
EBITDA -30.15M
Net Income Avi to Common (ttm)-31.17M
Diluted EPS (ttm)-2.1120
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.27M
Total Cash Per Share (mrq)0.5
Total Debt (mrq)5.32M
Total Debt/Equity (mrq)41.38
Current Ratio (mrq)3.11
Book Value Per Share (mrq)0.86

Cash Flow Statement

Operating Cash Flow (ttm)-28.5M
Levered Free Cash Flow (ttm)-20.82M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-85.69%
S&P500 52-Week Change 38.59%
52 Week High 36.0000
52 Week Low 30.5200
50-Day Moving Average 31.0943
200-Day Moving Average 31.4291

Share Statistics

Avg Vol (3 month) 3123.44k
Avg Vol (10 day) 368.87k
Shares Outstanding 526.71M
Float 16.03M
% Held by Insiders 177.03%
% Held by Institutions 143.57%
Shares Short (May 31, 2019) 4458.24k
Short Ratio (May 31, 2019) 44.18
Short % of Float (May 31, 2019) 42.34%
Short % of Shares Outstanding (May 31, 2019) 41.72%
Shares Short (prior month Apr 30, 2019) 4880.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A